---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000238"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2023-03-21T23:59:59+00:00"
generated_at: "2026-06-17T22:02:44.745122+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# India Globalization Capital rebrands as IGC Pharma, effective March 30, 2023

## Summary
- Name change to IGC Pharma, Inc. effective March 30, 2023; ticker symbol IGC unchanged.
- Company highlights focus on THC-based drug IGC-AD1 in Phase 2 trials for Alzheimer's agitation.
- IGC-AD1 is the only natural, THC-based investigational drug in FDA trials for Alzheimer's.
- Wellness brand Holief targets premenstrual syndrome, menstrual cramps, and sleep disorders.
- CEO Ram Mukunda states rebranding aligns name with strategic pharma focus.

## SEC filing metadata
- accession: 0001185185-23-000238
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2023-03-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000238/0001185185-23-000238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000238/indiaglob20230318_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000238
- JSON: https://secwatch.observer/filing/0001185185-23-000238.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000238.txt

## Key facts
- Governance Changes
  IGC Pharma, Inc.: Company changed name from India Globalization Capital Inc. to IGC Pharma, Inc. via Articles of Amendment to Amended and Restated Articles of Incorporation (effective 2023-03-30).
  - Change: charter amendment
  - Effective: 2023-03-30
  source text: Effective March 30, 2023, India Globalization Capital Inc., a Maryland corporation (the “we,” “our,” “us” or the “Company”), changed its name to “IGC Pharma, Inc.” by filing Articles of Amendment to the Company’s Amended and Restated Articles of Incorporation with the State Department of Assessments and Taxation of Maryland on March 7, 2023 (the “Charter Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000238/0001185185-23-000238-index.htm
- Governance Changes
  IGC Pharma, Inc.: Amended Amended and Restated Bylaws solely to reflect the name change (effective 2023-03-07).
  - Change: bylaw amendment
  - Effective: 2023-03-07
  source text: In addition, the Company adopted an Amendment to its Amended and Restated Bylaws, (the “Bylaw Amendment”), effective March 7, 2023, solely to reflect the name change.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000238/0001185185-23-000238-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.